{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreig4cpm4o4pq24kf76fwwsr626kemetad46feuu454lhbrhesvhcjy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mk57ja7eeva2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigf627bkdfztspxmbnw2y5346tohyxumvneluit6petjh7k5msoy4"
    },
    "mimeType": "image/jpeg",
    "size": 87563
  },
  "path": "/2026/04/22/aacr-2026-revolution-medicines-astrazeneca-oncology-research/?utm_campaign=rss",
  "publishedAt": "2026-04-22T18:29:47.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Health",
    "Pharma",
    "AACR",
    "AstraZeneca",
    "biotechnology",
    "Cancer",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.",
  "title": "STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more",
  "updatedAt": "2026-04-22T18:29:56.000Z"
}